Brazil's health regulator Anvisa said on Monday that it has approved trials with a third dose of the AstraZeneca vaccine against COVID-19.
Anvisa said a third dose of the vaccine would be administered to 10,000 volunteers between 11 and 13 months after the second shot.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.